scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BBRC.2005.07.100 |
P8608 | Fatcat ID | release_vqzsfo5cc5e3pb44542xt53vjm |
P698 | PubMed publication ID | 16081040 |
P50 | author | Koji Sode | Q55188802 |
P2093 | author name string | Natsuki Kobayashi | |
Eri Usuzaka | |||
Sayaka Ochiai | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Synuclein | Q24767155 |
P304 | page(s) | 432-436 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation | |
P478 | volume | 335 |
Q46069820 | Creation of aggregation-defective α-synuclein variants by engineering the sequence connecting β-strand-forming domains |
Q38843614 | Effect of reparation of repeat sequences in the human alpha-synuclein on fibrillation ability |
Q24293089 | Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity |
Q40893529 | The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein |
Search more.